Navigation Links
Bioniche Reports Fiscal 2007 Year-End Results
Date:9/26/2007

- consolidated revenues rise 3% over Fiscal 2006 to $27.5 million -

(all figures are in Canadian dollars unless otherwise noted)

BELLEVILLE, ON, Sept. 26 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2007 fiscal year ended June 30, 2007.

"The recent announcements of the first shipment and commercial usage of our E. coli O157:H7 cattle vaccine and the Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration for our second Phase III pivotal trial in bladder cancer occurred after the end of Fiscal 2007, but are the result of significant internal efforts during the fiscal year," noted Patrick Montpetit, Chief Financial Officer of Bioniche Life Sciences Inc. "During Fiscal 2007, we started our first Phase III clinical trial using our proprietary Mycobacterial Cell Wall-DNA Complex (MCC) in the treatment of bladder cancer patients whose condition is refractory (unresponsive) to the current standard therapy. We also closed a $17.5 million equity financing, with strong support from both institutional and individual investors."

Fiscal 2007 Financial Results Highlights

Consolidated revenues for the fiscal year increased by 3% to $27.5 million, as compared to $26.7 million in Fiscal 2006. The overall gross profit margin was 56% this fiscal year as compared to 57% in Fiscal 2006.

Expenses totalled $18.5 million for the 12 months ending June 30, 2007, which compares to $19.6 million recorded in the same period last year. This decrease of $1.1 million, or 6%, includes a decrease in interest on long-term debt and other interest associated with the refinancing and repayment of the Company's debt.

Gross research and development (R&D) expenses increased $2 million, or 16%, in Fiscal 2007, reaching $14.9 million compared to $12.9 million in Fiscal 2006. This is largely at
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 Governor ... 2015 application period for 43North - the world’s largest ... including a grand prize of $1 million, six $500,000 ... from around the world to compete for prizes that ... enterprises in the Western New York region. , ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... after dealing with certain matters, including the appointment of ... on March 26, 2015 (the "Meeting") was adjourned, as ... 2015 at 11:00 a.m. ( Toronto ... changed from that previous disclosed. The Meeting will reconvene ...
(Date:3/26/2015)... Massachusetts and CINCINNATI ... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... a three-year, broad research collaboration for rare diseases. The ... develop novel therapies to treat rare diseases with ... commercialization capabilities with Cincinnati Children,s research expertise. As ...
Breaking Biology Technology:Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5SQI Diagnostics Inc. Announces Adjournment of Meeting 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5
... Today sees the announcement of full details of how an ... at the forefront of research into ,wonder material, graphene. Also ... and research technology. 200 times stronger than ... strongest and thinnest material ever measured, and also the world,s ...
... PARK, Calif., Feb. 2, 2012 Auxogyn, Inc., a privately-held ... close of the final tranche of its Series A financing, ... was placed in May 2010, and investors in the round ... Serono Ventures. "Over the course of the last ...
... Feb. 2, 2012   Reportlinker.com announces that a ... its catalogue: U.S. Tissue ... The scope of this research ... companies in the wound care and surgery ...
Cached Biology Technology:New investment aims to establish the UK as a global graphene research hub 2New investment aims to establish the UK as a global graphene research hub 3Auxogyn Completes $20 Million In Series A Funding 2Auxogyn Completes $20 Million In Series A Funding 3U.S. Tissue Engineering Markets 2U.S. Tissue Engineering Markets 3
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates ...
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... Arsenic from treated lumber used in decks, utility poles ... decades to come, possibly threatening groundwater, according to two ... University of Miami, the University of Florida and Florida ... or CCA-treated wood, from a real deck as well ...
... , The recent discovery of a 90-million-year-old dinosaur ... carnivorous theropods that includes Velociraptor and is closely ... thought. Rather than originating during the Cretaceous, dromaeosaurs ... possibly as far back as 180 million years ...
... weapons used by our immune system to absorb and ... defence mechanism and even multiply within the macrophages. Cell ... a strategy in a recently publication in the journal ... findings reveal that the pathogens escape the 'stomach' of ...
Cached Biology News:Researchers: Treated wood poses long-term threat 2Researchers: Treated wood poses long-term threat 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 2Newly discovered birdlike dinosaur is oldest raptor ever found in South America 3Newly discovered birdlike dinosaur is oldest raptor ever found in South America 4Dangerous tricksters: Some bacterie use immune cells to reproduce 2Dangerous tricksters: Some bacterie use immune cells to reproduce 3
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
POU domain, class 2, transcription factor 2,...
... The CellSensor CRE-bla HEK 293T cell line ... of the cAMP response element (CRE). To ... was transduced into HEK 293T cells by ... isolate clones responsive to forskolin stimulation (Figure ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
Biology Products: